Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason Score

Prostate Cancer Genomic-risk Differences Between African-American and White Men Across Gleason Scores


Brandon A Mahal, Mohammed Alshalalfa, Daniel E Spratt, Elai Davicioni, Shuang G Zhao, Felix Y Feng, Timothy R Rebbeck, Paul L Nguyen, Franklin W Huang


African-American men have poorer prostate cancer-specific outcomes compared with white men [1]. Emerging evidence suggests that racial disparities in advanced stage or higher-grade disease may be predominantly accounted for by social factors and healthcare access [2,3]. In contrast, there is growing evidence to support the hypothesis that disparities in low-grade Gleason 6 disease may be in part driven by underlying tumor differences [3,4]. Although low-grade (Gleason 6) disease is considered prognostically favorable, it is associated with a diverse genomic landscape that can sometimes include aggressive genomic features [5].


Full text: https://www.europeanurology.com/article/S0302-2838(19)30011-9/fulltext

4 views0 comments

Recent Posts

See All

NIH Center for Global Health

Strategic Plan 2021-2025 Executive Summary The Center for Global Health (CGH) at the US National Cancer Institute (NCI) was established in 2011 to contribute to improved cancer control worldwide. Coin

Sequence three million genomes across Africa

Ambroise Wonkam COMMENT 10 FEBRUARY 2021 Capture the full scope of variation to improve health care, equity and medical research globally. PDF version Two decades after the completion of the Human Gen